Skip to content

PharmaCyte Biotech, Inc.

PMCB· NasdaqCore metricsCIK 1157075

Biological products, except diagnostic substances175 peers

Last sale
Oct 30, 2026 · -12.07%
Market cap
$3.28M
10.74M shares
Filings
473
$0.00
Q1 2027
-$5.08M
Q1 2027N/M FY26 yoy
-$1.01M
Q1 2027N/M FY26 yoy
—
—
—
-$0.54
Q1 2027N/M FY26 yoy
$17.74M
Q1 2027+22.6% FY26 yoy
$3.28M
—
—
0.1×
—
—

Twelve months to Jul 31, 2026 · derived

Price

$0.305168.22%$0.6549past year
Oct 30, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2026
$0.000FY 2015FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-04-30$0reported
FY 20252025-04-30$0reported
FY 20242024-04-30$0reported
FY 20232023-04-30$0reported
FY 20222022-04-30$0reported
FY 20212021-04-30$0reported
FY 20202020-04-30$0reported
FY 20192019-04-30$0reported
FY 20182018-04-30$0reported
FY 20172017-04-30$0reported
FY 20162016-04-30$0reported
FY 20152015-04-30$0reported

Capital returns

Dividends and buybacks · FY2022 to FY2026
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2026—$401.63K$401.63K—10.74M sh+58.0%—
FY2025—$2.54M$2.54M—6.80M sh−11.9%—
FY2024—$28.20M$28.20M—7.71M sh−12.2%—
FY2023—$13.56M$13.56M—8.78M sh−57.7%—
FY2022—$0.00$0.00—20.75M sh+0.1%—

Biological products, except diagnostic substances

PharmaCyte Biotech, Inc. is the 161st largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

PharmaCyte Biotech, Inc. · CIK 1157075 · Engraved from SEC EDGAR